Concord Biotech Limited IPO

Concord Biotech Limited is a R&D driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. Concord, founded in the year 2000 has transformed from a single-product company to a broad-spectrum solution provider, offering products across diversified therapeutic segments. Concord is globally known for its products and has a presence in more than 70 countries worldwide with efficient distribution infrastructure in markets like the USA, Europe, Japan, Latin America, Africa, Asia, besides significant presence in Indian market. Concord is actively expanding its horizons by partnering with leading global pharmaceutical companies by meeting their product development needs for APIs & finished formulations. Concord has world-class manufacturing infrastructure. The Company has two API manufacturing units and one finished formulation unit, all located near Ahmedabad, Gujarat, India.

Event	Minimum	Maximum
Lot	1 Lot	13 Lot
Shares	20 Shares	26 Shares
Amount	₹14,820	₹1,92,660

Company Name	Symbol	Listing Exchange	Issue Size	IPO Open Date	IPO Closing Date	IPO Listing Date
Concord Biotech Limited	CONCORDBIO	NSE, BSE	2,09,25,652	04 Aug 23	08 Aug 23	18 Aug 23

Face Value	Allotment Date	Refunds Date	Shares Credit in demat Date
₹1 per share	11 Aug 23	14 Aug 23	17 Aug 23